ERIKA REBELLO: Open Payments
NPI 1710521315 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 45 payments from 19 companies in 2025. Trend: 2023 $1,491 · 2024 $1,035 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $215 |
| Novartis Pharmaceuticals Corporation | 8 | $138 |
| Novo Nordisk Inc | 5 | $108 |
| PFIZER INC. | 3 | $59 |
| Ardelyx, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $33 |
Products named: AIRSUPRA, LEQVIO, Rybelsus, IBSRELA, MOUNJARO, VERQUVO, REXULTI, FARXIGA.
Industry payments across MA — which companies pay providers there.
